Seroprevalence of Hepatitis A in Indonesia part of "Seroprevalence of Hepatitis A in 3 South East Asian Countries: Indonesia, The Philippines And Vietnam"

Tahapan Penelitian : Awal
Sponsor:
Mitra Pelaksana:
Division of Gastrohepatology, Department of Child Health Faculty of Medicine Universitas Padjadjaran - Dr. Hasan Sadikin General Hospital Bandung, Indonesia
No Registry
INA-CLYNAA
Tanggal Input Registry : 15-06-2021

01-07-2021
To assess age prevalence trend of anti-HAV antibodies from two contrasting geographical areas in the population from Indonesia
• To estimate the age at midpoint of population immunity (AMPI) in the study population from Indonesia and area of study • To determine the strength of association of the known risk factors for HAV seropositivity in the study population
 
Seroprevalence of Hepatitis A in Indonesia part of "Seroprevalence of Hepatitis A in 3 South East Asian Countries: Indonesia, The Philippines And Vietnam"
Seroprevalence of Hepatitis A in Indonesia part of "Seroprevalence of Hepatitis A in 3 South East Asian Countries: Indonesia, The Philippines And Vietnam"
Observasional
This is study without intervention
1280
 

Inclusion Criteria:

1. Between 1-80 years of age 2. Willing to participate and provide Informed consent (and attestation for minors according to local good research practices) by participant or parent and/ or legal guardian for children. 3. Being resident (living during the last 6 months) in the selected geographic area

Exclusion Criteria:

1. Children in care 2. Receipt of immune globulins, blood or blood-derived products in last 3 months. 3. Bleeding disorder, or receipt of anticoagulants in the 3 weeks preceding inclusion, contraindicating blood drawing. 4. Attending to a health care institution due to gastrointestinal symptoms or icterical in the last 8 weeks 5. Individuals diagnosed Immunodeficiency condition 6. Individuals diagnosed with Terminal or psychiatric illness 7. Child, parent or other family member living the same household already enrolled as participant in this study.
 
409/UN6.KEP/EC/2021
Not Applicable
Not Applicable
EPI-HAV-013 BOD APA SUPP
Prof. Dr. Dwi Prasetyo dr.,Sp.A(K)., M.Kes; Yudith Setiati Ermaya dr., Sp.A(K)., M.Kes; Prof. Cissy B Kartasasmita dr., Sp.A(K)., MSc., PhD; Gustavo Hernandez-Suarez MD., MSc.